Bisoprolol BGR

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bisoprolol BGR

Quick Facts

Property Description
Active Ingredient Bisoprolol fumarate
Form Tablet (Oral)
Pharmacological Class Cardioselective Beta-1 Blocker
General Purpose Reduction of cardiac workload and blood pressure
Origin Synthetic compound

What Type of Medicine is Bisoprolol BGR?

Bisoprolol BGR is a pharmaceutical preparation delivered as an oral tablet, primarily containing the active ingredient Bisoprolol fumarate, a synthetic, single-agent compound. The drug is classified as a beta-adrenergic blocking agent, or a beta-blocker, and is available only by prescription. This agent falls under the broader therapeutic class of Antihypertensive Agents. Bisoprolol is recognized as a potent, long-acting agent characterized by its efficacy for once-daily dosing.

Understanding the Beta-Blocker Classification: Cardioselective beta1

Bisoprolol is critically defined as a cardioselective beta-1 blocker (beta1-selective agent) because it preferentially targets the beta1-adrenergic receptors, which are mainly located in the heart and in the juxtaglomerular cells of the kidney. This high degree of selectivity is the characteristic that sets Bisoprolol apart from non-selective analogues, which also affect beta2-receptors found in the lungs and peripheral blood vessels. This selectivity helps manage cardiac conditions with minimal impact on the airways compared to non-selective agents.

General Purpose: How Bisoprolol BGR Supports the Cardiovascular System

The overarching purpose of Bisoprolol BGR is to reduce the overall strain on the heart muscle. It achieves this by acting as a competitive antagonist, which mitigates the stimulating effects of the body's natural stress hormones, such as Epinephrine (adrenaline), on the cardiac tissue. By blocking this sympathetic stimulation, the drug lessens the heart's demand for oxygen, consequently lowering the heart's myocardial oxygen consumption and generally supporting the stabilization of blood pressure.

Regulatory References

  1. Bisoprolol - StatPearls
  2. Bisoprolol Public Assessment Report (MEB)

What side effects are possible with Bisoprolol BGR?

Bisoprolol BGR, like all medications, may cause side effects, although not everyone experiences them. It's essential to understand the potential effects and when to seek medical attention.

Common Side Effects

Side effects that are very common (may affect more than 1 in 10 people) or common (may affect up to 1 in 10 people) typically include:

System Common Side Effects (≥1/100 to <1/10)
General Fatigue, exhaustion, headache, dizziness (especially at the start of treatment or after dose changes).
Cardiovascular Slowed heart rate (bradycardia), feeling of coldness or numbness in the hands or feet.
Gastrointestinal Nausea, vomiting, diarrhea, constipation.

These common side effects are often mild and may lessen as your body adjusts to the medication.

Serious Warnings and Precautions

Do not stop taking Bisoprolol BGR abruptly, especially if you have coronary artery disease. Suddenly discontinuing the medication may worsen your heart condition, potentially leading to a heart attack or severe chest pain (angina). If treatment must be stopped, your doctor will slowly reduce the dosage over approximately one week.

Bisoprolol should be used with caution in certain patients, including those with asthma or other bronchospastic diseases, diabetes (as it may mask signs of low blood sugar, such as a fast heartbeat), or severe peripheral arterial occlusive disease (as symptoms may be aggravated).

Seek immediate medical attention if you experience signs of a serious adverse reaction, such as:

  • Worsening heart failure (e.g., shortness of breath, sudden weight gain, swelling of the ankles or feet).
  • Severe allergic reactions (e.g., rash, itching, swelling of the face, lips, tongue, or throat, or difficulty breathing).

Overdose and Emergency Response

Overdose and when to seek help

Documented Overdose Manifestations

Overdosage with Bisoprolol BGR may lead to a profound depression of vital functions. Regulatory documents list the most common expected signs as severe bradycardia (excessively slow heart rate), hypotension (low blood pressure), hypoglycemia (low blood sugar), and disturbances in cardiac conduction such as atrioventricular block. Respiratory symptoms, including bronchospasm, and central nervous system effects, such as confusion or extreme fatigue, are also formally documented.

When Immediate Medical Help is Required

Any suspected overdose is a medical emergency and requires immediate attention. Regulatory agencies instruct patients to seek immediate medical attention and contact emergency services without delay if the individual has collapsed, is experiencing a seizure, has trouble breathing, or cannot be awakened.

Severe Outcomes and Supportive Management

The severe consequences of overdose documented in official labeling include cardiogenic shock, acute worsening heart failure, and coma. In case of overdose, the therapy should be stopped, and supportive and symptomatic treatment must be provided. Hospital monitoring is required, often including observation of vital signs and an ECG. Limited data confirms the compound is not effectively removed by dialysis. A population-specific note is that low blood sugar is common in children during this type of overdose.

Therapeutic Uses of Bisoprolol BGR

Bisoprolol BGR plays a role in managing symptoms linked to organ-specific functional stress in the cardiovascular system, primarily by easing symptoms related to heightened physiological activity of the heart. The medication is commonly used across conditions presenting with systemic or localized discomfort and for the management of chronic conditions where functional stability is affected.

Bisoprolol is relevant for managing conditions characterized by periods of heightened symptoms, specifically including sustained high blood pressure (hypertension), chronic stable angina pectoris, stable heart failure with reduced ejection fraction (HFrEF), and certain cardiac arrhythmias requiring rate control.

“This application helps address symptoms that interfere with daily comfort by promoting rate control, which may assist with stabilizing an overly rapid heart rate.”

In these scenarios, Bisoprolol BGR is applied when appropriate for managing symptoms that interfere with daily functioning, which may assist with maintaining functional stability and supports general well-being during symptomatic phases.

Quick Fact: Relevant for Easing Symptoms Associated with Heightened Physiological Activity

Regulatory References

  1. NIH National Library of Medicine StatPearls

Eligibility and Restrictions for Use

Bisoprolol BGR eligibility is defined by official regulatory documentation, primarily confining its use to the adult population. Use is not recommended in children and adolescents, as its safety and effectiveness have not been established by regulatory authorities.

Absolute Contraindications

The medicine is strictly contraindicated and must not be used by individuals with specific, severe conditions. These exclusions include acute heart failure, cardiogenic shock, and severe cardiac conduction disorders such as second or third degree AV block (without a pacemaker), sick sinus syndrome, or symptomatic bradycardia. Patients with severe bronchial asthma, severe COPD, severe peripheral arterial occlusive disease, symptomatic hypotension, and metabolic acidosis are also formally prohibited from using the medicine.

Restricted and Conditional Use

Eligibility remains contingent on organ health: for patients with severe renal impairment or severe hepatic impairment, use is restricted, with official guidelines recommending a specific maximum daily dose should not be exceeded. In cases of diabetes mellitus, use requires caution as the medicine may mask symptoms of hypoglycemia. Use during pregnancy is permitted only if the potential benefit justifies the potential risk to the fetus, and use during lactation is generally not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Bisoprolol BGR is dominated by pharmacodynamic effects, primarily concerning other medicines that affect heart rate, contractility, or blood pressure. Regulatory documents formally classify certain combinations as high-risk.

Classification
Contraindicated Combinations
Other beta-blocking agents (including topical eye drops) are contraindicated due to the risk of profound additive systemic effects. Co-administration is also contraindicated with Floctafenine or Sultopride [1.6, 2.4].
Generally Not Recommended
Combinations with Calcium Antagonists of the Verapamil or Diltiazem type are generally not recommended due to negative influences on heart contractility and AV conduction. Centrally-acting Antihypertensive Drugs (e.g., Clonidine) are also generally not recommended, as their concurrent use may lead to an excessive reduction in heart function [2.3].

Other Documented Interaction Patterns

Interaction with Rifampicin, an antibiotic, is documented to increase Bisoprolol's metabolic clearance, which results in a shortened elimination half-life [1.8]. With Digitalis glycosides and Class I antiarrhythmic drugs, effects are additive in depressing AV conduction and heart rate [1.7].

Regulatory labeling addresses specific administration requirements for discontinuing therapy with a centrally-acting agent: if Clonidine is being withdrawn, Bisoprolol must be discontinued for several days prior to the Clonidine withdrawal to mitigate the risk of rebound hypertension [1.8, 4.1]. Long-term use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may result in a documented reduction of the hypotensive effect [1.7]. For individuals with Diabetes Mellitus, Bisoprolol may mask the symptoms of hypoglycemia, such as tachycardia [2.3].

Mechanism of Action

The action of Bisoprolol BGR is defined by its highly specific molecular interaction, which dampens the influence of the sympathetic nervous system on key regulatory centers.


Selective beta1 Receptor Blockade and Cardiac Modulation

The drug acts as a competitive antagonist, preferentially targeting the beta1-adrenergic receptors (beta1-AR) located primarily on the heart's conduction and muscle tissue . By occupying these receptors, Bisoprolol blocks stimulating hormones like Epinephrine, initiating a negative chronotropic effect (slowing heart rate) and a negative inotropic effect (reducing contraction force). This blockade results in a reduction of the heart muscle's overall metabolic oxygen demand and mechanical work.


Attenuation of the Neurohumoral System

The mechanism extends to the kidneys, where blockade of beta1-ARs on the juxtaglomerular cells suppresses the release of the enzyme renin. This action modifies the overall activity of the Renin-Angiotensin-Aldosterone System (RAAS), a major neurohumoral pathway that regulates fluid balance and vascular tone. This pathway interference modulates the systemic resistance mechanisms.


Constraints on Cardioselectivity

The high cardioselectivity of the drug is dose-dependent and represents a specific constraint on the mechanism. While it lacks Intrinsic Sympathomimetic Activity (ISA), its preferential targeting of beta1-AR is diminished at higher concentrations, increasing the likelihood of beta2-AR blockade in non-cardiac tissues. The drug's functional effect is also intrinsically dependent on the existing level of autonomic tone in the body.

Dosage and Administration Information

How to Use Bisoprolol BGR

Bisoprolol BGR is administered orally as a tablet, with defined parameters for the route, frequency, and dose adjustment. The medicine is consistently taken once daily in the morning, which helps establish a predictable schedule, and may be swallowed with or without food.


Dosing Regimens

Distinct dosing patterns are utilized based on the condition being addressed:

  • Hypertension and Angina: The typical starting dose is 5 mg once daily, with a usual maintenance dose of 10 mg. The maximum dose for these conditions is 20 mg per day.

  • Chronic Stable Heart Failure (CHF): Treatment begins with a very low initial dose, typically 1.25 mg once daily. This is followed by a slow, incremental titration (gradual dose increase over several weeks) to the maximum recommended maintenance dose of 10 mg once daily, provided the lower doses are well-tolerated.


Procedural and Population Constraints

The tablets should be swallowed whole with liquid and must not be chewed. If a dose is missed, it should be taken later that day, but a double dose must never be taken to compensate for the missed one.

Treatment with Bisoprolol BGR is intended to be long-term. If the medicine must be stopped, it is standard to use a gradual reduction (tapering) of the dose over approximately one to two weeks; abrupt cessation is avoided. Specific dose limits are required for patients with impaired organ function. For example, the daily dose should not exceed 10 mg in patients with severe renal impairment (creatinine clearance less than 20 mL/min) or severe hepatic impairment. Use is not recommended for pediatric patients due to insufficient clinical data.

Recent Clinical Evidence

Bisoprolol BGR: Recent Clinical Evidence


Evidence for Use in Stable Chronic Heart Failure

The research base for this indication is drawn from large, multi-year Randomized Controlled Trials (RCTs). These studies examined the use of the medicine alongside standard care, monitoring key outcomes such as all-cause mortality and the frequency of hospitalization due to heart failure. Findings describe patterns observed in these studies related to outcomes measured over follow-up periods that often lasted several years. Research also monitored changes in the heart's function and how patients reported their overall functional status over time. Data for certain groups remain insufficient, such as for patients experiencing the highest level of functional limitation or those with severe organ impairment.

Evidence for Use in Managing High Blood Pressure (Hypertension)

Research has explored the use of the medicine in adults with primary high blood pressure through various RCTs and ongoing observational studies. These studies monitored physiological outcomes related to systemic imbalance, specifically measuring changes in both systolic and diastolic blood pressure and changes in heart rate. Findings describe patterns observed in the studies related to these measured changes. While studies monitored changes in blood pressure, comparative evidence is still emerging against the newest fixed-dose combination treatments, and the role of this drug in initial treatment, relative to its use alongside other treatments, remains a point of exploration in current guideline development.

Evidence for Use in Chronic Stable Chest Pain (Angina Pectoris)

For stable chest pain, studies have explored the use of the drug in Randomized Crossover Trials. The research examined outcomes related to physical discomfort, such as the frequency of angina attacks and the use of rescue medication. Researchers also monitored physiological strain, measuring objective outcomes such as exercise capacity. Data for long-term outcomes (e.g., heart attack or mortality) for the sole indication of stable angina remain insufficient compared to the evidence base for heart failure. Few large trials have specifically examined how outcomes were measured for this drug as a strict monotherapy.

Long-term Studies and Follow-up

The most extensive long-term evidence was gathered in the large RCTs for stable chronic heart failure, with follow-up durations extending for one to several years. While a large body of long-term data on health outcomes exists for heart failure, the follow-up durations were more limited or shorter in many of the trials focused solely on high blood pressure or chronic stable angina relief.

What Is Still Uncertain About Bisoprolol BGR Research

Subgroup findings are uncertain for those with the highest levels of symptom severity or specific combinations of severe organ dysfunction. Comparative evidence is still emerging against some of the newest treatments. Research is ongoing, and future studies may provide additional context about the long-term patterns and application of this medicine in these more specialized patient groups.

Key Studies & References

  1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  2. Selective Beta-1 Blockers - StatPearls (NIH Contextual Review)
  3. Public Assessment Report (PAR) for Bisoprololfumaraat 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg, and 10 mg film-coated tablets (EU Regulatory Review)

Frequently Asked Questions (FAQ)

Common questions about Bisoprolol BGR (FAQ)


Q: Can Bisoprolol BGR be stopped suddenly without issues?

A: Official information states that abrupt withdrawal of treatment is strongly advised against, especially for individuals with coronary artery disease. Suddenly stopping the medicine may lead to a temporary worsening of the heart condition. If treatment must be stopped, it requires a gradual dose reduction managed by a healthcare provider.


Q: Does Bisoprolol BGR cause tiredness or fatigue?

A: Yes, tiredness, fatigue, and general exhaustion are listed in official documents as common side effects of Bisoprolol BGR. These effects are often mild and are typically observed at the beginning of treatment or after a dose change. These effects are often transient and may decrease as the body adjusts to the medicine.


Q: Does Bisoprolol BGR interact with common pain relievers like ibuprofen?

A: Official regulatory documents indicate that common pain relievers classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce the blood pressure-lowering effect of Bisoprolol BGR. Regulatory guidance recommends consulting a healthcare professional regarding all concurrent medications.


Q: What happens if I miss a dose of Bisoprolol BGR?

A: Regulatory guidance states that a missed dose should be taken later on the same day. However, it is strictly stated that a double dose must not be taken to make up for a missed dose. Maintaining a consistent daily schedule is important for the treatment to be effective.


Q: How does Bisoprolol BGR affect exercise and physical activity?

A: Bisoprolol BGR works by slowing your heart rate, which is known as a negative chronotropic effect. This effect reduces the heart's response to stress or activity, which may result in a lower maximum heart rate during exercise. This action reduces the heart's maximum work capacity during physical exertion.


Q: Does Bisoprolol BGR have a 'black box warning' in the US?

A: Official US labeling contains a prominent warning regarding the discontinuation of this drug, particularly for patients with coronary artery disease. This warning emphasizes the need for a gradual, controlled reduction of the dosage if discontinuation is necessary to avoid severe cardiac events.


Q: Is Bisoprolol BGR safe for long-term use?

A: Regulatory documentation for indications like stable chronic heart failure refers to Bisoprolol BGR as a long-term treatment. Approval is supported by clinical trials, some with follow-up over several years, which studied its use over extended periods.


Q: Is Bisoprolol BGR a generic medication?

A: Yes, the active ingredient in Bisoprolol BGR is Bisoprolol fumarate, which is available in a generic form. The BGR preparation is approved by regulatory bodies as a generic equivalent to the original brand-name product.


Q: How quickly does Bisoprolol BGR start to work for blood pressure?

A: According to official pharmacodynamic studies, the maximal effect of the medicine on lowering heart rate occurs between one to four hours after you take a dose. The overall effects of the medicine are generally designed to last for 24 hours to support once-daily dosing.


Q: Is weight gain a potential side effect of Bisoprolol BGR?

A: Official information lists changes in weight as a potential adverse effect. Furthermore, rapid or unusual weight gain is noted as a symptom that requires monitoring, as it can sometimes be a sign of a worsening underlying heart condition.


Q: Are there any common foods or drinks to avoid while taking Bisoprolol BGR?

A: Official regulatory prescribing information states that Bisoprolol BGR tablets can be taken with or without food, as food does not significantly affect how the medicine is absorbed. No specific common food interactions (like grapefruit) are noted in the official regulatory labels.


Q: Is there a link between Bisoprolol BGR and changes in mood?

A: Official adverse event listings note that psychiatric disorders, including depression, are documented as a less common side effect. Sleep disorders and anxiety are also noted in official documents as potential effects.


Q: Can Bisoprolol BGR affect sleep or cause nightmares?

A: Official product information lists sleep disorders, which includes difficulty falling asleep (insomnia), as an uncommon side effect. Nightmares are also noted in regulatory documents as a rare side effect that has been reported.


Q: Do regulatory agencies have warnings about driving while taking Bisoprolol BGR?

A: Regulatory information warns that the medicine may cause effects like dizziness, fatigue, or fainting (syncope), especially when treatment begins or when the dose changes. Caution is advised when driving or operating machinery until you know how the medicine affects you.


Q: Does official information suggest Bisoprolol BGR can cause erectile dysfunction?

A: Yes, official adverse event listings note that potency disorders, including erectile dysfunction, are reported as a rare side effect of the medicine.


Q: Can Bisoprolol BGR affect blood sugar levels?

A: Regulatory documents indicate that Bisoprolol BGR can potentially influence blood sugar control. Importantly, the medicine may mask certain symptoms of low blood sugar, such as a rapid heart rate, in patients who are taking medications for diabetes.


Q: Does Bisoprolol BGR interact with herbal supplements?

A: Official public health guidance often recommends that patients disclose all products they are taking, including herbal remedies and supplements. This is because these products are not typically tested for interactions in the same way as prescription drugs, and they could still potentially affect the safety or effectiveness of Bisoprolol BGR.


Q: Why is it important not to share Bisoprolol BGR with others?

A: Bisoprolol BGR is a prescription-only medicine that has been approved for use only under the care and guidance of a healthcare professional. Its use is based on a personal medical evaluation, and it must only be used by the person for whom it was specifically prescribed.


Q: What is the official guidance on taking Bisoprolol BGR with a multivitamin?

A: While no specific warning exists for all multivitamins, some authoritative drug interaction resources suggest that minerals like calcium or magnesium may potentially reduce the absorption or effect of Bisoprolol BGR. To limit this risk, separating the administration of the two products by at least two hours is often advised.


Q: Is there official information about Bisoprolol BGR and hair loss?

A: Yes, official adverse event listings note that alopecia, or hair loss, is a very rare side effect that has been reported during treatment with this drug.


Q: Does Bisoprolol BGR affect cholesterol levels?

A: Regulatory documentation lists changes in blood fats, such as increased triglycerides and changes in cholesterol levels, as rare findings reported in clinical investigations of the medicine.


Q: What happens if a child accidentally takes Bisoprolol BGR?

A: Bisoprolol BGR is not recommended for children and adolescents due to a lack of established safety data. Accidental ingestion of blood pressure medication by a child is considered a serious medical event, and emergency attention is strongly advised.


Q: Are there any specific monitoring requirements while taking Bisoprolol BGR?

A: Official guidelines emphasize the need for close monitoring of vital signs, such as heart rate and blood pressure, particularly during the initial phase when the dose is being slowly adjusted (titration). This monitoring is implemented to assess tolerance and treatment response.


Q: Is it possible to be allergic to Bisoprolol BGR?

A: Yes, official prescribing information lists hypersensitivity, which is an allergic reaction to Bisoprolol or any of the ingredients in the tablet, as a formal contraindication. Allergic reactions, such as a rash, are also reported as rare adverse events.


Q: Are there different tablet colors or shapes for different strengths of Bisoprolol BGR?

A: The official descriptive information for the tablets indicates that different strengths are often manufactured with distinct characteristics. This may include differences in color, shape, embossing (markings), or scoring (lines) to help patients and caregivers easily distinguish between the various doses.

How should Bisoprolol BGR be stored and disposed of?

How to Store and Dispose of Bisoprolol BGR

Bisoprolol tablets must be stored according to defined regulatory conditions to ensure product quality and stability. The medicine must be kept at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with storage limits not exceeding 30 C.

Storage Requirements

  • Protection: The product must be protected from light and moisture and should be stored in the original container or a tight, light-resistant container.
  • Safety: The tablets must be stored out of the sight and reach of children.

Disposal Instructions

Any unused or expired Bisoprolol must be disposed of in accordance with local requirements for pharmaceutical waste. Regulatory documents explicitly instruct that the medicine must not be thrown away via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bisoprolol BGR found in:

A-Z Index: